
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Structural and functional characterizations of infectivity and immune evasion of SARS-CoV-2 Omicron
Zhen Cui, Pan Liu, Nan Wang, et al.
Cell (2022) Vol. 185, Iss. 5, pp. 860-871.e13
Open Access | Times Cited: 387
Zhen Cui, Pan Liu, Nan Wang, et al.
Cell (2022) Vol. 185, Iss. 5, pp. 860-871.e13
Open Access | Times Cited: 387
Showing 1-25 of 387 citing articles:
BA.2.12.1, BA.4 and BA.5 escape antibodies elicited by Omicron infection
Yunlong Cao, Ayijiang Yisimayi, Fanchong Jian, et al.
Nature (2022) Vol. 608, Iss. 7923, pp. 593-602
Open Access | Times Cited: 1226
Yunlong Cao, Ayijiang Yisimayi, Fanchong Jian, et al.
Nature (2022) Vol. 608, Iss. 7923, pp. 593-602
Open Access | Times Cited: 1226
Imprinted SARS-CoV-2 humoral immunity induces convergent Omicron RBD evolution
Yunlong Cao, Fanchong Jian, Jing Wang, et al.
Nature (2022)
Open Access | Times Cited: 573
Yunlong Cao, Fanchong Jian, Jing Wang, et al.
Nature (2022)
Open Access | Times Cited: 573
SARS-CoV-2 Omicron variant: recent progress and future perspectives
Yao Fan, Xiang Li, Lei Zhang, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 484
Yao Fan, Xiang Li, Lei Zhang, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 484
Enhanced neutralization resistance of SARS-CoV-2 Omicron subvariants BQ.1, BQ.1.1, BA.4.6, BF.7, and BA.2.75.2
Panke Qu, John P. Evans, Julia N. Faraone, et al.
Cell Host & Microbe (2022) Vol. 31, Iss. 1, pp. 9-17.e3
Open Access | Times Cited: 247
Panke Qu, John P. Evans, Julia N. Faraone, et al.
Cell Host & Microbe (2022) Vol. 31, Iss. 1, pp. 9-17.e3
Open Access | Times Cited: 247
Imprinted SARS-CoV-2 humoral immunity induces convergent Omicron RBD evolution
Yunlong Cao, Fanchong Jian, Jing Wang, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 214
Yunlong Cao, Fanchong Jian, Jing Wang, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 214
A Detailed Overview of SARS-CoV-2 Omicron: Its Sub-Variants, Mutations and Pathophysiology, Clinical Characteristics, Immunological Landscape, Immune Escape, and Therapies
Srijan Chatterjee, Manojit Bhattacharya, Sagnik Nag, et al.
Viruses (2023) Vol. 15, Iss. 1, pp. 167-167
Open Access | Times Cited: 210
Srijan Chatterjee, Manojit Bhattacharya, Sagnik Nag, et al.
Viruses (2023) Vol. 15, Iss. 1, pp. 167-167
Open Access | Times Cited: 210
Omicron (BA.1) and sub‐variants (BA.1.1, BA.2, and BA.3) of SARS‐CoV‐2 spike infectivity and pathogenicity: A comparative sequence and structural‐based computational assessment
Suresh Kumar, Kalimuthu Karuppanan, Gunasekaran Subramaniam
Journal of Medical Virology (2022) Vol. 94, Iss. 10, pp. 4780-4791
Open Access | Times Cited: 192
Suresh Kumar, Kalimuthu Karuppanan, Gunasekaran Subramaniam
Journal of Medical Virology (2022) Vol. 94, Iss. 10, pp. 4780-4791
Open Access | Times Cited: 192
Tracking SARS-CoV-2 Omicron diverse spike gene mutations identifies multiple inter-variant recombination events
Junxian Ou, Wendong Lan, Xiaowei Wu, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 191
Junxian Ou, Wendong Lan, Xiaowei Wu, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 191
Molecular basis of receptor binding and antibody neutralization of Omicron
Hong Qin, Wenyu Han, Jiawei Li, et al.
Nature (2022) Vol. 604, Iss. 7906, pp. 546-552
Open Access | Times Cited: 189
Hong Qin, Wenyu Han, Jiawei Li, et al.
Nature (2022) Vol. 604, Iss. 7906, pp. 546-552
Open Access | Times Cited: 189
Structural diversity of the SARS-CoV-2 Omicron spike
S. Gobeil, Rory Henderson, Victoria Stalls, et al.
Molecular Cell (2022) Vol. 82, Iss. 11, pp. 2050-2068.e6
Open Access | Times Cited: 179
S. Gobeil, Rory Henderson, Victoria Stalls, et al.
Molecular Cell (2022) Vol. 82, Iss. 11, pp. 2050-2068.e6
Open Access | Times Cited: 179
Modeling of waning immunity after SARS-CoV-2 vaccination and influencing factors
Laura Pérez‐Alós, José Juan Almagro Armenteros, Johannes Roth Madsen, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 168
Laura Pérez‐Alós, José Juan Almagro Armenteros, Johannes Roth Madsen, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 168
Characterization of the enhanced infectivity and antibody evasion of Omicron BA.2.75
Yunlong Cao, Weiliang Song, Lei Wang, et al.
Cell Host & Microbe (2022) Vol. 30, Iss. 11, pp. 1527-1539.e5
Open Access | Times Cited: 159
Yunlong Cao, Weiliang Song, Lei Wang, et al.
Cell Host & Microbe (2022) Vol. 30, Iss. 11, pp. 1527-1539.e5
Open Access | Times Cited: 159
Repeated Omicron exposures override ancestral SARS-CoV-2 immune imprinting
Ayijiang Yisimayi, Weiliang Song, Jing Wang, et al.
Nature (2023) Vol. 625, Iss. 7993, pp. 148-156
Open Access | Times Cited: 156
Ayijiang Yisimayi, Weiliang Song, Jing Wang, et al.
Nature (2023) Vol. 625, Iss. 7993, pp. 148-156
Open Access | Times Cited: 156
Structural basis of human ACE2 higher binding affinity to currently circulating Omicron SARS-CoV-2 sub-variants BA.2 and BA.1.1
Linjie Li, Hanyi Liao, Yumin Meng, et al.
Cell (2022) Vol. 185, Iss. 16, pp. 2952-2960.e10
Open Access | Times Cited: 144
Linjie Li, Hanyi Liao, Yumin Meng, et al.
Cell (2022) Vol. 185, Iss. 16, pp. 2952-2960.e10
Open Access | Times Cited: 144
Structural and functional impact by SARS-CoV-2 Omicron spike mutations
Jun Zhang, Yongfei Cai, Christy L. Lavine, et al.
Cell Reports (2022) Vol. 39, Iss. 4, pp. 110729-110729
Open Access | Times Cited: 143
Jun Zhang, Yongfei Cai, Christy L. Lavine, et al.
Cell Reports (2022) Vol. 39, Iss. 4, pp. 110729-110729
Open Access | Times Cited: 143
Omicron SARS-CoV-2 mutations stabilize spike up-RBD conformation and lead to a non-RBM-binding monoclonal antibody escape
Zhennan Zhao, Jingya Zhou, Mingxiong Tian, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 123
Zhennan Zhao, Jingya Zhou, Mingxiong Tian, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 123
Cryo-EM structure of a SARS-CoV-2 omicron spike protein ectodomain
Gang Ye, Bin Liu, Fang Li
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 118
Gang Ye, Bin Liu, Fang Li
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 118
Molecular characteristics, immune evasion, and impact of SARS-CoV-2 variants
Cong Sun, Chu Xie, Guo‐Long Bu, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 118
Cong Sun, Chu Xie, Guo‐Long Bu, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 118
SARS‐CoV‐2 Omicron variant: Immune escape and vaccine development
Danyi Ao, Tianxia Lan, Xuemei He, et al.
MedComm (2022) Vol. 3, Iss. 1
Open Access | Times Cited: 109
Danyi Ao, Tianxia Lan, Xuemei He, et al.
MedComm (2022) Vol. 3, Iss. 1
Open Access | Times Cited: 109
Towards SARS-CoV-2 serotypes?
Etienne Simon‐Lorière, Olivier Schwartz
Nature Reviews Microbiology (2022) Vol. 20, Iss. 4, pp. 187-188
Open Access | Times Cited: 104
Etienne Simon‐Lorière, Olivier Schwartz
Nature Reviews Microbiology (2022) Vol. 20, Iss. 4, pp. 187-188
Open Access | Times Cited: 104
Omicron variant (B.1.1.529) and its sublineages: What do we know so far amid the emergence of recombinant variants of SARS-CoV-2?
Manish Dhawan, AbdulRahman A. Saied, Saikat Mitra, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 154, pp. 113522-113522
Open Access | Times Cited: 97
Manish Dhawan, AbdulRahman A. Saied, Saikat Mitra, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 154, pp. 113522-113522
Open Access | Times Cited: 97
Cryo-EM structures of SARS-CoV-2 Omicron BA.2 spike
Victoria Stalls, Jared Lindenberger, S. Gobeil, et al.
Cell Reports (2022) Vol. 39, Iss. 13, pp. 111009-111009
Open Access | Times Cited: 94
Victoria Stalls, Jared Lindenberger, S. Gobeil, et al.
Cell Reports (2022) Vol. 39, Iss. 13, pp. 111009-111009
Open Access | Times Cited: 94
SARS-CoV-2: Evolution and Emergence of New Viral Variants
Verónica Roxana Flores-Vega, Jessica Viridiana Monroy-Molina, Luis Enrique Jiménez-Hernández, et al.
Viruses (2022) Vol. 14, Iss. 4, pp. 653-653
Open Access | Times Cited: 92
Verónica Roxana Flores-Vega, Jessica Viridiana Monroy-Molina, Luis Enrique Jiménez-Hernández, et al.
Viruses (2022) Vol. 14, Iss. 4, pp. 653-653
Open Access | Times Cited: 92
SARS-CoV-2 spike L452R mutation increases Omicron variant fusogenicity and infectivity as well as host glycolysis
Yanan Zhang, Ting Zhang, Yihui Fang, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 85
Yanan Zhang, Ting Zhang, Yihui Fang, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 85
Atlas of currently available human neutralizing antibodies against SARS-CoV-2 and escape by Omicron sub-variants BA.1/BA.1.1/BA.2/BA.3
Min Huang, Lili Wu, Anqi Zheng, et al.
Immunity (2022) Vol. 55, Iss. 8, pp. 1501-1514.e3
Open Access | Times Cited: 84
Min Huang, Lili Wu, Anqi Zheng, et al.
Immunity (2022) Vol. 55, Iss. 8, pp. 1501-1514.e3
Open Access | Times Cited: 84